BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260918
DTSTAMP:20260515T013446
CREATED:20260430T095220Z
LAST-MODIFIED:20260430T095220Z
UID:43419-1789430400-1789689599@www.pharmajournalist.com
SUMMARY:9th Neuropsychiatric Drug Development Summit
DESCRIPTION:The Neuropsychiatric Drug Development Summit is the definitive meeting for biopharma leaders shaping the future of psychiatric R&D. At a time of renewed momentum in neuropsychiatry\, this summit brings together senior decision‑makers to redefine how the industry translates science into successful\, patient‑centred therapies. \nAcross discovery\, translational science\, and clinical development\, the agenda showcases the most promising advances in the field — from psychedelics\, muscarinics\, orexins\, and novel neuroplasticity approaches to cutting‑edge translational tools such as EEG\, digital and speech biomarkers\, sleep endpoints\, and smarter patient stratification. Attendees will gain practical insights into overcoming placebo response\, heterogeneity\, and late‑stage failure through biology‑driven\, regulatory‑ready strategies. \nDesigned for meaningful connection and collaboration\, the summit offers an intimate\, highly interactive environment to exchange data\, challenge assumptions\, and build partnerships with peers tackling depression\, schizophrenia\, bipolar disorder\, anxiety\, PTSD\, and addiction. Join the global community accelerating the next era of precision psychiatry. \nFind out more today – https://ter.li/rt2cakk3
URL:https://www.pharmajournalist.com/event/9th-neuropsychiatric-drug-development-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR